CRISPR-Based Diagnostics Global Market Report 2025
상품코드:1716936
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 175 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
CRISPR 기반 진단약 시장 규모는 향후 수년간 급성장이 전망됩니다. 2029년에는 CAGR 17.9%로 99억 2,000만 달러로 성장합니다. 예측 기간 중 예상되는 성장은 신속하고 정확한 진단에 대한 수요 증가, 감염성 질환 검출에 대한 적용 확대, 정부 및 기관의 자금 지원 증가, 항생제 내성 검출 개선, CRISPR 기술에 대한 인식과 수용성 증가 등의 요인에 기인합니다. 이 기간 중 예상되는 주요 동향으로는 현장진단(POC) 검사, CRISPR-Cas12 및 Cas13 시스템 사용, 맞춤의료 및 유전자 스크리닝의 주요 발전, 나노테크놀러지 및 바이오센서와의 통합, CRISPR 기반 조기 질병 감지 방법의 개발 등이 있습니다.
감염성 질환의 발병률 증가는 CRISPR 기반 진단 시장 확대를 촉진할 것으로 예측됩니다. 감염성 질환은 박테리아, 바이러스, 곰팡이, 기생충과 같은 병원성 미생물에 의해 발생하며, 사람 간 또는 오염된 표면, 음식, 물, 곤충과 같은 매개체를 통해 전파될 수 있습니다. 이러한 질병의 발생 빈도 증가는 세계화, 항생제 내성, 기후 변화, 도시화, 인구 증가, 서식지 파괴, 의료 접근성 제한 등의 요인으로 인해 발생 빈도가 증가하고 있으며, CRISPR 기반 진단은 신속하고 정확한 병원체 검출, 조기 진단, 신속한 개입, 효과적인 봉쇄 전략의 실현을 통해 감염병 퇴치를 지원합니다. 예를 들어 2024년 8월 영국 행정기관인 UK Health Security Agency(UKHSA)의 데이터에 따르면 2023년 영국에서 368건의 홍역 환자가 보고된 것으로 나타났습니다. 이는 2022년 53건에서 7배 가까이 증가한 것으로, 웨스트미들랜드가 44%, 런던이 33%를 차지했습니다. 결과적으로 감염성 질환의 발생률 증가가 CRISPR 기반 진단약 시장의 성장을 촉진하고 있습니다.
CRISPR 기반 진단 시장 주요 기업은 CRISPR 기반 현장 진단을 통해 신속하고 정확한 진단에 대한 접근성을 개선하기 위해 전략적 파트너십을 체결하는 사례가 증가하고 있습니다. 전략적 파트너십은 공동의 목표를 달성하고 경쟁력을 강화하기 위해 자원과 전문성을 결집하는 조직 간의 장기적인 협력 관계를 포함합니다. 예를 들어 2023년 8월 인도에 본사를 둔 생명공학 기업 CrisprBits Private Limited는 인도의 분자진단 회사 Molbio Diagnostics와 전략적 제휴를 맺었습니다. 이번 제휴는 병원체 및 유전자 마커를 검출하기 위한 신속하고 정확하며 비용 효율적인 진단 솔루션을 제공하는 CRISPR 기반 POCT(Point-of-Care Test) 개발에 초점을 맞추었습니다. CrisprBits의 CRISPR 플랫폼에 대한 전문성과 Morbio의 제조 및 판매 역량을 결합하여, CrisprBits의 CRISPR 플랫폼 전문성과 Morbio의 제조 및 판매 역량을 결합함으로써, 이번 제휴는 이러한 검사를 전 세계 시장에 출시하는 것을 목표로 하고 있습니다. 시장에 도입하는 것을 목표로 하고 있습니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 동향과 전략
제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나바이러스의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계 CRISPR 기반 진단약PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 용도 산업의 분석
세계의 CRISPR 기반 진단약 시장 : 성장률 분석
세계의 CRISPR 기반 진단약 시장 실적 : 규모와 성장, 2019-2024
세계의 CRISPR 기반 진단약 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계 CRISPR 기반 진단약 TAM(Total Addressable Market)
제6장 시장 세분화
세계의 CRISPR 기반 진단약 시장 : 제품별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
키트
완충액
소프트웨어
기타 제품
세계의 CRISPR 기반 진단약 시장 : 기술별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
RPA(Recombinase Polymerase Amplification)
루프 개재 등온 증폭(LAMP)
기타 테크닉
세계의 CRISPR 기반 진단약 시장 : 질환별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
감염증
비감염성 질환
세계의 CRISPR 기반 진단약 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원
진단 센터
바이오테크놀러지 기업
학술연구기관
기타 최종사용자
세계의 CRISPR 기반 진단약 시장, 키트의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
CRISPR 탐지 키트
CRISPR 증폭 키트
CRISPR 기반 어세이 키트
세계의 CRISPR 기반 진단약 시장, 완충액의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
CRISPR 반응 버퍼
CRISPR 용해 버퍼
세계의 CRISPR 기반 진단약 시장, 소프트웨어의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
CRISPR 데이터 해석 소프트웨어
CRISPR 설계 소프트웨어
CRISPR 진단 플랫폼 소프트웨어
세계의 CRISPR 기반 진단약 시장, 기타 제품의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
CRISPR 효소
CRISPR 시약
CRISPR 기반 프로브
제7장 지역별·국가별 분석
세계의 CRISPR 기반 진단약 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 CRISPR 기반 진단약 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
CRISPR 기반 진단약 시장 : 경쟁 구도
CRISPR 기반 진단약 시장 : 기업 개요
Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
Integrated DNA Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
Molbio Diagnostics Overview, Products and Services, Strategy and Financial Analysis
Horizon Discovery Overview, Products and Services, Strategy and Financial Analysis
Beam Therapeutics Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 대기업과 혁신적 기업
Intellia Therapeutics Inc.
Synthego Corporation
Caribou Biosciences
Mammoth Biosciences
Verve Therapeutics
Editas Medicine
Epic Bio
Sherlock Biosciences
Addgene
VedaBio
CrisprBits
SNIPR BIOME ApS
TOLO Biotech
Intact Genomics
Agdia Inc.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 합병과 인수
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
CRISPR 기반 진단약 시장 2029 : 새로운 기회를 제공하는 국가
CRISPR 기반 진단약 시장 2029 : 새로운 기회를 제공하는 부문
CRISPR 기반 진단약 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁의 전략
제36장 부록
KSA
영문 목차
영문목차
CRISPR-based diagnostics refers to advanced molecular tools that utilize the CRISPR-Cas system to detect specific nucleic acid sequences with high precision and speed, enabling the identification of diseases or genetic markers. This technology offers groundbreaking capabilities in medical and genomic analysis. CRISPR-based diagnostics are used in applications such as detecting infectious diseases, identifying genetic disorders, and monitoring mutations in cancer research and treatment. It also holds significant potential in personalized medicine and point-of-care testing.
The primary products in CRISPR-based diagnostics include kits, buffer solutions, software, and other components. CRISPR diagnostic kits are ready-to-use tools designed for the rapid and accurate detection of specific genetic material, frequently applied in disease diagnosis and research. Techniques used in this process include recombinase polymerase amplification (RPA), loop-mediated isothermal amplification (LAMP), and others. These diagnostics are used for both infectious and non-infectious diseases and are employed by hospitals, diagnostic centers, biotechnology companies, academic and research institutions, among others.
The CRISPR-based diagnostics market research report is one of a series of new reports from The Business Research Company that provides CRISPR-based diagnostics market statistics, including CRISPR-based diagnostics industry global market size, regional shares, competitors with CRISPR-based diagnostics market share, detailed CRISPR-based diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the CRISPR-based diagnostics industry. This CRISPR-based diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The CRISPR-based diagnostics market size has grown rapidly in recent years. It will grow from $4.35 billion in 2024 to $5.14 billion in 2025 at a compound annual growth rate (CAGR) of 18.1%. The growth observed during the historic period can be attributed to factors such as an increase in healthcare expenditure, a rising demand for gene editing, a higher prevalence and incidence of chronic diseases, growing awareness of available treatments, and a rise in the prevalence of genetic disorders.
The CRISPR-based diagnostics market size is expected to see rapid growth in the next few years. It will grow to $9.92 billion in 2029 at a compound annual growth rate (CAGR) of 17.9%. The growth projected for the forecast period can be attributed to factors such as the increasing demand for rapid and accurate diagnostics, expanding applications in infectious disease detection, rising government and institutional funding, improved detection of antibiotic resistance, and growing awareness and acceptance of CRISPR technologies. Key trends anticipated during this period include point-of-care (POC) testing, the use of CRISPR-Cas12 and Cas13 systems, advancements in personalized medicine and genetic screening, integration with nanotechnology and biosensors, and the development of CRISPR-based early disease detection methods.
The growing incidence of infectious diseases is expected to drive the expansion of the CRISPR-based diagnostics market. Infectious diseases are caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites, which can spread from person to person or through contaminated surfaces, food, water, or vectors such as insects. The rising frequency of these diseases is attributed to factors including globalization, antibiotic resistance, climate change, urbanization, population growth, habitat destruction, and limited access to healthcare. CRISPR-based diagnostics support the fight against infectious diseases by offering rapid and accurate pathogen detection, enabling early diagnosis, prompt intervention, and effective containment strategies. For example, in August 2024, data from the UK Health Security Agency (UKHSA), a UK-based executive agency, revealed that 368 measles cases were reported in England in 2023. This represented a nearly sevenfold increase from the 53 cases in 2022, with the West Midlands and London accounting for 44% and 33% of the cases, respectively. As a result, the increasing incidence of infectious diseases is driving the growth of the CRISPR-based diagnostics market.
Major players in the CRISPR-based diagnostics market are increasingly forming strategic partnerships to improve access to rapid and accurate diagnostics through CRISPR-based point-of-care tests. A strategic partnership involves a long-term collaboration between organizations that combine their resources and expertise to achieve shared goals and strengthen their competitive edge. For example, in August 2023, CrisprBits Private Limited, a biotechnology company based in India, entered into a strategic collaboration with Molbio Diagnostics, an Indian molecular diagnostics company. This partnership focuses on developing CRISPR-based point-of-care tests (POCTs) that offer rapid, precise, and cost-effective diagnostic solutions for detecting pathogens and genetic markers. The goal is to enhance diagnostic accessibility in various environments, including resource-limited areas, while ensuring quick and accurate disease detection. By combining CrisprBits' CRISPR platform expertise with Molbio's manufacturing and distribution capabilities, the collaboration aims to introduce these tests to a global market.
In February 2024, Ginkgo Bioworks Holdings Inc., a biotechnology company based in the United States, acquired Proof Diagnostics Inc. for an undisclosed amount. The acquisition is intended to enhance Ginkgo's gene therapy services by incorporating Proof Diagnostics' OMEGA RNA-programmable nuclease technology, thereby improving its gene editing capabilities. This strategic move strengthens Ginkgo's ability to offer advanced solutions in therapeutic development and precision gene editing. Proof Diagnostics Inc. is a US-based company that specializes in CRISPR-based molecular testing solutions for COVID-19.
Major players in the crispr-based diagnostics market are Thermo Fisher Scientific Inc., Integrated DNA Technologies Inc., Molbio Diagnostics, Horizon Discovery, Beam Therapeutics, Intellia Therapeutics Inc., Synthego Corporation, Caribou Biosciences, Mammoth Biosciences, Verve Therapeutics, Editas Medicine, Epic Bio, Sherlock Biosciences, Addgene, VedaBio, CrisprBits, SNIPR BIOME ApS, TOLO Biotech, Intact Genomics, Agdia Inc., and ToolGen Inc.
North America was the largest region in the CRISPR-based diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in CRISPR-based diagnostics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the CRISPR-based diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The CRISPR-based diagnostics market includes revenues earned by entities by providing services such as diagnostic testing services, custom CRISPR assays development, screening and surveillance services, and regulatory and compliance services. The market value includes the value of related goods sold by the service provider or included within the service offering. The CRISPR-based diagnostics market also consists of sales of CRISPR-based RNA detection systems, CRISPR-based monitoring tools, lateral flow assays, and CRISPR-based test platforms. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
CRISPR-Based Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on crispr-based diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for crispr-based diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The crispr-based diagnostics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product: Kits; Buffer Solutions; Software; Other Products
2) By Technique: Recombinase Polymerase Amplification (RPA); Loop-mediated Isothermal Amplification (LAMP); Other Techniques
3) By Disease: Infectious Diseases; Non-Infectious Diseases
4) By End-User: Hospitals; Diagnostic Centers; Biotechnology Companies; Academic And Research Institutes; Other End-Users
3. CRISPR-Based Diagnostics Market Trends And Strategies
4. CRISPR-Based Diagnostics Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global CRISPR-Based Diagnostics Growth Analysis And Strategic Analysis Framework
5.1. Global CRISPR-Based Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global CRISPR-Based Diagnostics Market Growth Rate Analysis
5.4. Global CRISPR-Based Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global CRISPR-Based Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global CRISPR-Based Diagnostics Total Addressable Market (TAM)
6. CRISPR-Based Diagnostics Market Segmentation
6.1. Global CRISPR-Based Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Kits
Buffer Solutions
Software
Other Products
6.2. Global CRISPR-Based Diagnostics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Recombinase Polymerase Amplification (RPA)
Loop-mediated Isothermal Amplification (LAMP)
Other Techniques
6.3. Global CRISPR-Based Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Infectious Diseases
Non-Infectious Diseases
6.4. Global CRISPR-Based Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Diagnostic Centers
Biotechnology Companies
Academic And Research Institutes
Other End-Users
6.5. Global CRISPR-Based Diagnostics Market, Sub-Segmentation Of Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
CRISPR Detection Kits
CRISPR Amplification Kits
CRISPR-Based Assay Kits
6.6. Global CRISPR-Based Diagnostics Market, Sub-Segmentation Of Buffer Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
CRISPR Reaction Buffers
CRISPR Lysis Buffers
6.7. Global CRISPR-Based Diagnostics Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
CRISPR Data Analysis Software
CRISPR Design Software
CRISPR Diagnostic Platforms Software
6.8. Global CRISPR-Based Diagnostics Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
CRISPR Enzymes
CRISPR Reagents
CRISPR-Based Probes
7. CRISPR-Based Diagnostics Market Regional And Country Analysis
7.1. Global CRISPR-Based Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global CRISPR-Based Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
